Navigation Links
CLAAD Petitions FDA To Reject Opioid Medications Without Safety Features
Date:6/11/2013

WASHINGTON, June 11, 2013 /PRNewswire-USNewswire/ -- The Center for Lawful Access and Abuse Deterrence (CLAAD) joined in signing a Citizen Petition filed today urging the Food and Drug Administration (FDA) to fully implement the Obama administration's policy supporting a market transition to safer opioid medications. The petition asks that the FDA reject applications for new opioid medications without added safety features.

Opioids are a class of synthetically derived chemicals often used to treat pain or addiction. Opioid analgesics were involved in over 16,000 overdose deaths in 2010 alone, according to the Centers for Disease Control.

The petition praises the FDA's recent steps to shift the market to safer medications, such as the April conclusion that the original OxyContin pill was removed from the market for safety reasons. Copies of the non-abuse-deterrent formulation will not be approved because of this decision.

Recent FDA decisions regarding generic opioids cloud the future of abuse-deterrent medications. In May, the FDA ruled that manufacturers will be allowed to bring to market as early as July 1 more generic forms of a non-abuse deterrent version of Opana ER. The FDA is also expected to decide soon whether to approve an application for a new, pure hydrocodone pill with no abuse-deterrent features.

CLAAD's executive director, Michael Barnes, explained the need for action: "The availability of more generic, non-abuse-deterrent opioids increases the supply of drugs that people are eager and able to abuse. The better approach is to replace that supply with abuse-deterrent medications."

The citizen petition is asking that the FDA act speedily in accordance with the urgency of the national prescription abuse epidemic. By law, the FDA has 180 days to reply.

About the Center for Lawful Access and Abuse Deterrence
The not-for-profit

SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CLAAD Warns of Increase in Prescription Drug Overdoses
2. CLAAD Names Eagle Advancement Institute as Honoree of Top 5 Technologies To Reduce Prescription Drug Abuse
3. CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
4. CLAAD Recognizes SMART/Script as Top 5 Technology To Reduce Rx Abuse
5. CLAAD Recognizes The Locking Cap as Top 5 Technology To Reduce Rx Abuse
6. CLAAD Selects Egalet As Top Five Technologies To Reduce Prescription Drug Abuse Honoree
7. Abuse Deterrent Medicines Developer Pisgah Laboratories, Inc. Wins Top 5 Technologies Award from CLAAD
8. TRICAST Debuts Part D Rejection Oversight Solution for Drug Plan Sponsors
9. Home Affairs Committees Drugs Report: Angelus Foundation Says the Prime Minister Should Not Have Rejected a Royal Commission
10. Express Scripts Recommends Rejection of TRC Capitals "Mini-Tender" Offer
11. New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 Ardelyx, Inc. (NASDAQ: ... gastrointestinal and cardio-renal diseases, today announced that Sanofi ... and license agreement for Ardelyx,s portfolio of NaP2b ... payment associated with termination and the return of ... Sanofi entered into an option and license agreement ...
(Date:9/1/2015)... 1, 2015 Emerus Holdings, a national ... inpatient and diagnostic care in partnership with leading ... definitive agreement to receive a strategic investment from ... leading health care investment firm. Emerus ... acute episodic and ambulatory clinical services to communities ...
(Date:9/1/2015)... --  Alpha Imaging LLC , a leading distributor of advanced medical ... that they have been awarded exclusive rights to represent the complete ... new territory supplements Alpha Imaging,s existing Shimadzu sales and service responsibilities ... , Indiana , Pennsylvania , ... West Virginia , Delaware and ...
Breaking Medicine Technology:Ardelyx Regains NaP2b Program from Sanofi 2Ardelyx Regains NaP2b Program from Sanofi 3Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 3Alpha Imaging Expands Shimadzu Territory 2
... at Brigham and Women,s,Hospital found that patients taking cannabinoid ... were unrelated to relief from their pain,symptoms. Results ... the addictive,potential of this class of pain medicine, were ... Annual Meeting. , In the ...
... The Netherlands, January 28 ,Amsterdam Molecular Therapeutics ... of,human gene therapy, announced today during the ... showing that one treatment of its lead ... and clinically important,lowering of the incidence of ...
Cached Medicine Technology:Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief 2AMT: Glybera(R) Lowers Pancreatitis Incidence Significantly 2AMT: Glybera(R) Lowers Pancreatitis Incidence Significantly 3
(Date:9/1/2015)... ... September 01, 2015 , ... Horizon Blue Cross Blue Shield of New Jersey ... in the LATINA Style 50 Report that recognizes companies that provide the best career ... Horizon BCBSNJ climbs from number 24 to 21 of the 50 Best Companies for ...
(Date:9/1/2015)... Eagan, Minnesota (PRWEB) , ... September 01, 2015 ... ... covered health care delivery options, Blue Cross and Blue Shield of Minnesota (Blue ... starting in 2016. , Based in San Francisco, Doctor On Demand provides ...
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN in Houston, TX ... , an innovative vaginal health laser procedure that prevents and resolves dryness in ... atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, painful intercourse and ...
(Date:9/1/2015)... Burlington, MA (PRWEB) , ... September 01, 2015 ... ... for remote real-time monitoring and analysis of pet vital signs and activity, today ... Cornerstone is one of the most popular and widely-adopted veterinary hospital Practice Management ...
(Date:9/1/2015)... ... ... Royal River Natural Foods, a locally-owned independent natural health store in Freeport, ... and found that, among those who had a stroke, people who used multivitamins survived ... the September 2015 issue of “Natural Insights for Well Being,” which Royal River Natural ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2
... 30% in 2007, ... to Millennium Research Group, WALTHAM, Mass., Feb. 25 ... or equal to 3.0 mm),dental implants are becoming increasingly popular ... faster rate than those of regular-diameter,(> 3.0 mm) dental implants., ...
... anxious about their skin condition say they are less likely ... at the University of Bath (UK). , The study, published ... middle-aged adults recruited from a national acne support group. , ... participate in sport or exercise, acne sufferers who perceived their ...
... Aware,s AccuRad client/server software suite enables remote browser-based, ... bandwidth-constrained network, BEDFORD, Mass., Feb. 25 ... and biometrics software, today,announced it will showcase the ... the 2008 Annual HIMSS Conference & Exhibition. HIMSS08,is ...
... Inc. (OTC Bulletin,Board: IAGX), announced today that the ... Committee has selected Celadrin(R),Topical Cream as its Official ... provide the best medical care for the athletes ... has expanded its goal to provide the most,advanced ...
... 25, 2008 A vaginal microbicide that incorporates an antiretroviral ... safe for sexually active HIV-negative women to use every day ... of tenofovir topical gel. Moreover, most of the women who ... States adhered to a regimen involving either daily or sex-dependent ...
... (Nasdaq:,LCAV), a leading provider of laser vision correction services ... vision center in Des,Moines, Iowa. This marks the 74th ... LasikPlus vision center in the state of Iowa.,LasikPlus vision ... markets., Similar to other LasikPlus vision centers throughout ...
Cached Medicine News:Health News:Small-Diameter Dental Implants Increasingly Popular In the US 2Health News:Acne may prevent people from participating in sport and exercise, says research 2Health News:Aware, Inc. to Demonstrate Groundbreaking Medical Imaging Streaming Solution at HIMSS08 2Health News:Aware, Inc. to Demonstrate Groundbreaking Medical Imaging Streaming Solution at HIMSS08 3Health News:Aware, Inc. to Demonstrate Groundbreaking Medical Imaging Streaming Solution at HIMSS08 4Health News:Aware, Inc. to Demonstrate Groundbreaking Medical Imaging Streaming Solution at HIMSS08 5Health News:International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as it's First and Only Official Joint and Muscle Topical Cream 2Health News:International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as it's First and Only Official Joint and Muscle Topical Cream 3Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 2Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 3Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 4Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 5Health News:Trial finds tenofovir gel safe for daily use and most women adhered to study regimens 6Health News:LCA-Vision Announces the Opening of its 74th LasikPlus Vision Center in Des Moines, Iowa 2
Used to negotiate tortuous vessels....
BiodivYsio stent with biocompatible coating (phosphorylcholine)...
... The CYPHER Sirolimus-eluting Coronary Stent ... drug, called "sirolimus", a controlled-release ... delivery platform. Upon placement, sirolimus ... and impedes the process of ...
PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig...
Medicine Products: